- Home
- USLM vs PTGX Comparison
USLM vs PTGX Comparison
Compare USLM & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USLM
- PTGX
- Stock Information
- Founded
- USLM 1948
- PTGX 2006
- Country
- USLM United States
- PTGX United States
- Employees
- USLM N/A
- PTGX N/A
- Industry
- USLM Other Metals and Minerals
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- USLM Industrials
- PTGX Health Care
- Exchange
- USLM Nasdaq
- PTGX Nasdaq
- Market Cap
- USLM 2.5B
- PTGX 2.8B
- IPO Year
- USLM N/A
- PTGX 2016
- Fundamental
- Price
- USLM $98.28
- PTGX $43.40
- Analyst Decision
- USLM
- PTGX Strong Buy
- Analyst Count
- USLM 0
- PTGX 8
- Target Price
- USLM N/A
- PTGX $66.50
- AVG Volume (30 Days)
- USLM 78.8K
- PTGX 1.1M
- Earning Date
- USLM 04-30-2025
- PTGX 05-06-2025
- Dividend Yield
- USLM 0.24%
- PTGX N/A
- EPS Growth
- USLM 50.52
- PTGX N/A
- EPS
- USLM 4.20
- PTGX 0.86
- Revenue
- USLM $337,287,000.00
- PTGX $207,801,000.00
- Revenue This Year
- USLM N/A
- PTGX N/A
- Revenue Next Year
- USLM N/A
- PTGX $7.13
- P/E Ratio
- USLM $23.70
- PTGX $50.92
- Revenue Growth
- USLM 17.83
- PTGX N/A
- 52 Week Low
- USLM $64.25
- PTGX $24.22
- 52 Week High
- USLM $159.53
- PTGX $60.60
- Technical
- Relative Strength Index (RSI)
- USLM 55.63
- PTGX 49.93
- Support Level
- USLM $96.51
- PTGX $41.29
- Resistance Level
- USLM $100.75
- PTGX $46.12
- Average True Range (ATR)
- USLM 3.45
- PTGX 1.74
- MACD
- USLM 0.68
- PTGX -0.06
- Stochastic Oscillator
- USLM 70.04
- PTGX 61.14
About USLM United States Lime & Minerals Inc.
United States Lime & Minerals Inc is engaged in the business of manufacturing lime and limestone products including PLS, quicklime, hydrated lime and lime slurry. It supplies its products predominantly to the construction (including highway, road, and building contractors), industrial (including paper and glass manufacturers), environmental (including municipal sanitation and water treatment facilities and flue gas treatment processes), metals (including steel producers), oil and gas services, roof shingle manufacturers and agriculture (including poultry and cattle feed producers) industries. The company operates through its Lime and Limestone Operations segment.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.